@article{article, title  = {{PCN259 SHOULD HEALTH STATE UTILITY VALUES (HSUVS) IN CANCER IMMUNOTHERAPIES (IOS) BE ANALYZED BY TIME TO DEATH (TTD) OR PROGRESSION STATUS? RESULTS OF A SIMULATION STUDY}},

 publisher = {{Elsevier BV}},

 url = {{}},

 year = {{2019}},

 month = {{5}},

 author = {{Hatswell AJ and Bullement A and Schlichting M and Bharmal M}},

 doi = {{10.1016/j.jval.2019.04.380}},

 volume = {{22}},

 journal = {{Value in Health}},

 pages = {{S105-S105}},

 note = {{Accessed on 2024/12/22}}}